CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) of $15.57 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-27.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease · last filed 2012-02-27
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2011-12-31 was $15.09M, a 109.75% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2011-09-24 was $144.00K, a 73.49% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2010-12-25 was $7.19M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2010-09-25 was $83.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2011 was $15.57M, a 108.91% increase from fiscal 2010.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2010 was $7.45M, a 17.76% increase from fiscal 2009.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2009 was $6.33M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2008 was -$7.46M.
| Period end | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 9 month | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 12 month | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 12 month as first filed |
|---|---|---|---|---|---|
| 2011-12-31 | $15.09M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $15.23M derived: sum of 2 quarters · filed 2012-02-27 | $15.57M 10-K · filed 2012-02-27 | ||
| 2011-09-24 | $144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $483.00K 10-Q · filed 2011-11-02 | |||
| 2011-06-25 | $339.00K 10-Q · filed 2011-08-03 | ||||
| 2010-12-25 | $7.19M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $7.28M derived: sum of 2 quarters · filed 2012-02-27 | $7.45M 10-K · filed 2012-02-27 | -$7.45M 10-K · filed 2011-02-23 | |
| 2010-09-25 | $83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $260.00K 10-Q · filed 2011-11-02 | |||
| 2010-06-26 | $177.00K 10-Q · filed 2011-08-03 | ||||
| 2009-12-26 | $6.33M 10-K · filed 2012-02-27 | -$6.33M 10-K · filed 2011-02-23 | |||
| 2008-12-27 | -$7.46M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |